Pharmacy profit managers face new, sweeping necessities to reveal all of the alternative ways they get cash from offering drug protection.
The proposed rule from the Division of Labor revealed on Thursday could be a big change for an trade that shields prescription drug information from employers and ceaselessly locks its purchasers into restrictive contracts. Federal officers estimate the elevated transparency may save employers and staff $1 billion yearly as they’ve entry to decrease drug costs and really take their medicines.
Employers and governments rent PBMs to barter drug costs, create lists of coated medicine, construct networks of pharmacies, and course of drug claims. Labor attorneys, watchdogs, and even staff have warned giant employers that they’re overpaying for medicine.
This text is unique to STAT+ subscribers
Unlock this text — plus each day intelligence on Capitol Hill and the life sciences trade — by subscribing to STAT+.
Have already got an account? Log in
To learn the remainder of this story subscribe to STAT+.